1. Home
  2. CYTK vs MNDY Comparison

CYTK vs MNDY Comparison

Compare CYTK & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$63.34

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo monday.com Ltd.

MNDY

monday.com Ltd.

HOLD

Current Price

$115.48

Market Cap

7.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
MNDY
Founded
1997
2012
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.4B
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
CYTK
MNDY
Price
$63.34
$115.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
16
24
Target Price
$84.81
$255.58
AVG Volume (30 Days)
1.8M
1.5M
Earning Date
02-26-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
192.87
EPS
N/A
1.23
Revenue
$87,211,000.00
$1,166,095,000.00
Revenue This Year
$341.94
$28.81
Revenue Next Year
$75.44
$21.01
P/E Ratio
N/A
$93.60
Revenue Growth
2609.26
28.62
52 Week Low
$29.31
$113.80
52 Week High
$70.98
$342.64

Technical Indicators

Market Signals
Indicator
CYTK
MNDY
Relative Strength Index (RSI) 49.19 24.22
Support Level $62.13 $124.34
Resistance Level $65.88 $131.31
Average True Range (ATR) 2.59 5.88
MACD 0.07 -1.22
Stochastic Oscillator 54.84 5.42

Price Performance

Historical Comparison
CYTK
MNDY

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About MNDY monday.com Ltd.

Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.

Share on Social Networks: